Fusion event
HBV-chr20 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGA| |TTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCA
End
26081156/26100520 (Hg38)
Nearest miRNA
hsa-mir-103a-2/Upstream/7629829; hsa-mir-1-1/Downstream/107666;
Upstream sequence
CCACATATTATGAGATAATGAATATATTCATTATCTCAATTCATAAAACAATCATGTGATTTAGTTGGTGTTATTACTAGATTATTACCATTGtacaagt
Downstream sequence
aaagaaaataaagacaaaaaaaaaaaaagaaaagagactcagcaaaatcaaaccaataaagacttaatcagaattgttgggcatataataaaaatttaat
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.